Fidson Healthcare Limited 2024 Interim Results For The First Quarter

Fidson Healthcare Limited ( Q12024 Interim Report

By Published On: April 30, 2024TYPE: Interim ReportsYear: 2024Period: Q1Country: NigeriaSector: Health

Fidson Healthcare Limited ( listed on the Nigerian Stock Exchange under the Health sector has released its 2024 interim results for the first quarter.

For more information about Fidson Healthcare Limited ( reports, abridged reports, interim earnings results and earnings presentations visit the Fidson Healthcare Limited ( company page on AfricanFinancials.

Indicative Share Trading Liquidity

The total indicative share trading liquidity for Fidson Healthcare Limited ( in the past 12 months, as of 1st April 2024, is US$2.84M (NGN2.27B). An average of US$236.56K (NGN189M) per month.

Fidson Healthcare Limited 2024 interim results for the first quarter

Company Profile

Fidson Healthcare Limited manufactures and sells pharmaceutical and nutraceutical products in Nigeria including over-the-counter, ethical and consumer products. The company produces various drug classes for antacid and ulcer care, anti-diabetic, anti-malaria, anti-diarrhea, anti-psychotic as well as osteo-care, pain relief, colds and flu, thrombo-prophylactics and cardio-vascular products. Fidson Healthcare Limited also produces a range of nutraceuticals (health) products. The company was incorporated in 1995 and its head office is in Shomolu, Nigeria. Fidson Healthcare Limited is listed on the Nigerian Stock Exchange